Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 AUD | -0.60% | -8.58% | -18.54% |
03/06 | Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland | MT |
24/05 | Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.54% | 27Cr | |
+15.37% | 4.2TCr | |
+22.56% | 2.23TCr | |
+14.89% | 1.52TCr | |
+16.53% | 1.4TCr | |
+49.78% | 1.21TCr | |
-10.77% | 679.6Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+14.55% | 549.33Cr |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents